Abstract
Renal transplantation is recognized as the optimal treatment for end-stage renal disease (ESRD), offering improved survival rates and quality of life compared to dialysis. However, renal transplant recipients face a significantly increased risk of developing renal cell carcinoma (RCC), with a risk approximately five to six times higher than that of the general population. This case report highlights both the incidence and histological subtypes of RCC in renal transplant patients, emphasizing the notable prevalence of papillary RCC. This subtype occurs in 40% of cases among transplant recipients, compared to only 10 – 15% in the general population. We discuss a case involving a 30-year-old male patient who had a significant family history of hereditary renal disease. He progressed to ESRD, received a living renal transplant, and developed papillary RCC 15 years post-transplant in the transplanted kidney. Additionally, we present findings from multiple studies worldwide, highlighting the extensive data collected and the implications of long-term follow-up for monitoring outcomes of RCC. Our findings emphasize the need for increased awareness and regular screening for RCC in this high-risk population.
Published on: December 02, 2024
doi: 10.17756/micr.2024-111
Citation: Murad S, Alsayed M, Rammal B, Shihata S, Krimli D, et al. 2024. Incidental Occurrence of Papillary Renal Carcinoma in Kidney Transplant Recipient: A Case Report. J Med Imaging Case Rep 8(2): 49-51.
Downloads